Related by context. All words. (Click for frequent words.) 75 Traficet EN 75 CTAP# Capsules 75 Panzem R NCD 75 liposomal formulation 74 MAGE A3 ASCI 74 YONDELIS 74 IMA# 74 Ophena TM 74 oral ridaforolimus 74 forodesine 74 Azedra 73 orally administered inhibitor 73 Phase #b/#a clinical 73 demonstrated antitumor activity 73 ELACYT 73 cilengitide 73 CIMZIA TM 73 Panzem R 73 Aflibercept 73 ZOLINZA 73 PEGylated Fab fragment 73 targeted radiotherapeutic 73 PEG SN# 73 pomalidomide 73 Archexin 73 oral prodrug 73 Tarceva TM 72 BZL# 72 receptor tyrosine kinase inhibitor 72 PSMA ADC 72 alvespimycin 72 relapsed MM 72 radiation sensitizer 72 CoFactor 72 Xanafide 72 docetaxel Taxotere ® 72 IRX 2 72 elacytarabine 72 PNP inhibitor 72 PRT# 72 alfa 2a 71 teriflunomide 71 INCB# [001] 71 rindopepimut 71 Omacetaxine 71 Irinotecan 71 HuMax CD4 71 phase IIb clinical 71 Amrubicin 71 Telintra 71 targeting CD# 71 mertansine 71 eniluracil 71 EOquin TM 71 huN# DM1 71 SinuNase TM 71 OHR/AVR# 71 histone deacetylase HDAC inhibitor 71 R#/MEM # 71 EndoTAG TM -1 71 HGS ETR1 71 TELINTRA 71 Fibrillex TM 71 CR# vcMMAE 71 antibody MAb 71 nucleoside analog 71 ganetespib 71 plasma kallikrein inhibitor 71 CIMZIA ™ 71 K ras mutations 71 thalidomide Thalomid 71 LymphoStat B belimumab 71 Allovectin 7 R 71 LY# [003] 71 Peginterferon alfa 2b 70 elotuzumab 70 Abiraterone acetate 70 docetaxel Taxotere R 70 GW# [003] 70 HCD# [002] 70 Ozarelix 70 monoclonal antibody conjugated 70 Pimavanserin 70 2 methoxyestradiol 70 huC# DM4 70 Allovectin 7 70 BAY #-# 70 Laquinimod 70 mapatumumab 70 Sym# 70 methylnaltrexone 70 estramustine 70 selective modulator 70 acyclovir Lauriad R 70 recurrent glioblastoma multiforme 70 Chemophase 70 Troxatyl 70 lenalidomide Revlimid R 70 orally bioavailable 70 HuMax EGFr 70 ZACTIMA 70 dasatinib Sprycel ® 70 ixabepilone 70 Daclizumab 70 sorafenib Nexavar 70 OncoVEX GM CSF 70 leukemia AML 70 denileukin diftitox 70 pertuzumab 70 Apoptone 70 paclitaxel poliglumex 70 Solazed 70 humanized anti 70 sorafenib tablets 70 oral rivaroxaban 70 Vidaza azacitidine 70 ara C 70 ENMD # 70 MAXY G# 70 Tanespimycin 70 CYT# potent vascular disrupting 70 JAK inhibitor 70 decitabine 70 Raptiva ® 70 AAG geldanamycin analog 70 tanespimycin 70 novel VDA molecule 70 Temsirolimus 70 OvaRex R 70 Fludara ® 70 refractory chronic lymphocytic 70 CCX# 70 DDP# 70 PEGylated interferon beta 1a 70 novel histone deacetylase 70 indibulin 70 investigational monoclonal antibody 70 HQK 70 amrubicin 70 Personalized Immunotherapy 70 RhuDex ® 70 Tyrima 70 non nucleoside inhibitor 70 HGS# 70 BrachySil TM 69 Bafetinib 69 GSK# [001] 69 ELND# 69 systemically administered 69 fosbretabulin 69 UPLYSO 69 refractory gout 69 Doxil ® 69 Allovectin 7 ® 69 EndoTAGTM 1 69 systemic RNAi therapeutic 69 vidofludimus 69 orally dosed 69 Phase 2b Clinical Trial 69 erlotinib Tarceva ® 69 Quinamed 69 LHRH agonists 69 Elagolix 69 alkylating agent 69 MGd 69 velafermin 69 PRTX 69 PI3K/Akt pathway inhibitor 69 #D#C# 69 imatinib therapy 69 CCX# B 69 Dasatinib 69 superficial bladder cancer 69 HspE7 69 Glufosfamide 69 PDE4 inhibitor 69 Randomized Phase 69 budesonide foam 69 Alocrest 69 HGS ETR1 mapatumumab 69 recurrent metastatic 69 lumiliximab 69 Virulizin ® 69 CANCIDAS 69 docetaxel chemotherapy 69 pan HDAC inhibitor 69 SNT MC# 69 lintuzumab SGN 69 evaluating tivozanib 69 Aclidinium 69 melphalan prednisone 69 Pharmacokinetics PK 69 AQ4N 69 riociguat 69 GnRH antagonist 69 ThermoDox R 69 Symadex 69 Cloretazine 69 ARIKACE 69 Vicinium TM 69 MKC# MT 69 PROMACTA 69 HCV protease inhibitors 69 Capesaris 69 Trastuzumab 69 KRN# 69 Vidofludimus 69 Pralatrexate 69 KNS # 69 Teriflunomide 69 atacicept 69 Xyfid TM 69 EOquin 69 cisplatin gemcitabine 69 Dapagliflozin 69 Mipomersen 69 intranasal formulation 69 HCV SPRINT 69 trabectedin 69 metaglidasen 69 prucalopride 69 ATL# [002] 69 axitinib 69 FluCide 69 MT# MEDI 69 AEGR 69 recurrent NSCLC 69 Talabostat 69 AVASTIN 69 dasatinib Sprycel 69 ularitide 69 proteasome inhibitor 69 omega interferon 69 DCVax ® 69 Xeloda ® 69 Paraplatin ® 69 Elotuzumab 69 GLPG# 69 Lenocta 69 IIa trial 69 Epratuzumab 69 thymalfasin 69 BENLYSTA TM 69 GRNVAC1 69 mycophenolate mofetil 69 Maribavir 69 Natalizumab 69 Civacir 69 administered subcutaneously 69 E1 INT TM 69 ACTEMRA TM 69 heavily pretreated patients 69 AEG# 69 metastatic hormone refractory 69 baminercept 69 lapatinib Tykerb 69 LEUKINE 69 HER2 positive metastatic breast 69 Gleevec resistant 69 ATL# [001] 69 Exelixis compounds 69 pegfilgrastim 69 octreotide acetate 69 NP2 Enkephalin 69 targeted antifolate 69 Aurexis 69 gefitinib Iressa 69 HGS ETR2 68 5 Fluorouracil 68 pegylated liposomal doxorubicin 68 bortezomib Velcade 68 PEGylated interferon 68 Interferon alpha 68 Ecallantide 68 RhuDex TM 68 Pazopanib 68 Plicera 68 CEQ# 68 Factor VIIa 68 urocortin 2 68 lomitapide 68 Seliciclib 68 xenograft models 68 Mitoxantrone 68 talactoferrin 68 Clolar ® 68 cetuximab Erbitux R 68 DAVANAT 68 hypereosinophilic syndrome 68 relapsing multiple sclerosis 68 paclitaxel Taxol ® 68 Pirfenidone 68 Certolizumab pegol 68 CA4P 68 TroVax ® 68 XL# XL# 68 TRO# 68 phase IIa clinical 68 Tamibarotene 68 castrate resistant prostate cancer 68 FASLODEX 68 depsipeptide 68 interferon gamma 1b 68 sitaxsentan 68 Insegia 68 SPRYCEL ® 68 pradefovir 68 dosing cohort 68 refractory indolent non 68 castration resistant prostate cancer 68 HRPC 68 TELCYTA 68 Arikace 68 GVAX ® 68 registrational trial 68 OvaRex ® MAb 68 ONTAK 68 corticosteroid dexamethasone 68 Saxagliptin 68 Onconase 68 TYGACIL 68 XL# anticancer compounds 68 reslizumab 68 Azacitidine 68 Zolinza 68 HuLuc# 68 Thiarabine 68 TTF Therapy 68 Pertuzumab 68 VAPRISOL 68 Vandetanib 68 Poly ICLC 68 sunitinib malate 68 PEG IFN 68 Annamycin 68 HDAC Inhibitor 68 gemcitabine cisplatin 68 Neulasta ® 68 Phase IIb trials 68 formerly LymphoStat B 68 IMiDs 68 galiximab 68 interferon alfa 68 hA# 68 Cytoxan 68 otelixizumab 68 anti leukemic 68 Cimzia TM 68 DOXIL 68 Adjuvant Treatment 68 Simulect 68 LymphoStat B TM 68 PEGylated anti 68 treatment naive genotype 68 immunomodulatory therapy 68 histone deacetylase inhibitor 68 investigational humanized monoclonal antibody 68 romidepsin 68 Nanobody 68 virus HCV protease inhibitor 68 TBC# 68 Tesmilifene 68 metastatic malignant 68 myelodysplastic myeloproliferative diseases 68 Aplidin 68 Sapacitabine 68 Xcellerated T Cells 68 Pradefovir 68 catheter occlusion 68 enzastaurin 68 mg/m2 dose 68 Octreotide 68 standard chemotherapy regimen 68 paclitaxel Taxol R 68 Menerba 68 XL# SAR# 68 PF # [002] 68 bevacizumab Avastin ® 68 IL# PE#QQR 68 oxaliplatin Eloxatin 68 visilizumab 68 aflibercept 68 Cloretazine ® 68 Copegus ribavirin 68 Ixempra 68 R sorafenib tablets 68 cannabinor 68 Vascugel 68 Syncria 68 adriamycin 68 rilonacept 68 CD3 monoclonal antibody 68 FIRMAGON 68 Intravenous CP 68 paclitaxel Taxol 68 gemcitabine carboplatin 68 recurrent glioma 68 PKC# 68 MKC# MKC# PP 68 CINTREDEKIN BESUDOTOX 68 busulfan 68 Kinoid 68 brivaracetam 68 Perifosine 68 angiogenesis inhibitor 68 CRLX# 68 goserelin 68 Onalta ™ 68 synthetic retinoid 68 octreotide implant 68 Platinol ® 68 Golimumab 68 LHRH antagonist 68 Ataluren 68 Luteinizing Hormone Releasing Hormone 68 TG# [003] 68 Genasense ® 68 IMC #B 68 ISF# 68 anti EGFR antibody 68 ribavirin RBV 68 DermaVir Patch 68 Ceplene/IL-2 68 SCH # 68 ErbB2 positive 68 Darinaparsin 68 LEP ETU 68 CIMZIA TM certolizumab pegol 68 nalbuphine ER 68 PXD# 68 relapsed SCLC 68 AGILECT R 68 Degarelix 68 epithelial tumors 68 ALN TTR 68 TYZEKA 68 Romiplostim 68 Zavesca R 68 dopamine partial agonist 68 ISTODAX 68 FUSILEV enhances 67 Peginterferon 67 interferon beta therapy 67 herpetic keratitis 67 Silodosin 67 FOLFOX chemotherapy 67 trastuzumab Herceptin R 67 Pegylated Interferon 67 Ophena 67 Velcade bortezomib 67 Antitumor Activity 67 XYOTAX TM 67 PANVAC VF 67 volociximab 67 Xelox 67 dose cohort 67 generation purine nucleoside 67 bendamustine 67 CYT# QbG# 67 G#DT 67 oral nucleoside analogue 67 samalizumab 67 fluoropyrimidine 67 Aliskiren 67 deforolimus 67 CCR5 antagonist 67 DPX Survivac 67 Aptivus ® 67 diarrhea predominant irritable 67 calcineurin inhibitor 67 Guanilib 67 Aurora Kinase 67 Parathyroid Hormone 67 inhibitor RG# 67 BAL# [002] 67 efaproxiral 67 Phase 2a trial 67 Achieves Primary Endpoint 67 relapsed ovarian cancer 67 Pafuramidine 67 Phase IIb clinical trials 67 Gemzar gemcitabine 67 Anthim 67 Amplimexon 67 Myocet 67 Cethromycin 67 heavily pretreated 67 zanolimumab 67 PDX pralatrexate 67 metastatic CRC 67 trastuzumab DM1 T DM1 67 posaconazole 67 nitazoxanide 67 Rebif ® 67 oral talactoferrin 67 Carfilzomib 67 IgG1 monoclonal antibody 67 Torisel 67 Camptosar ® 67 reversible inhibitor 67 malignant ascites 67 TACI Ig 67 alemtuzumab Campath 67 CD# CEA 67 Afatinib 67 TLK# 67 metastatic castration resistant 67 AKT inhibitor 67 beta 1a 67 MyVax R 67 VEGFR2 inhibitor 67 Arranon 67 Pemetrexed 67 telaprevir VX 67 custirsen 67 MORAb 67 XL# XL# XL# XL# 67 SinuNase ™ 67 favorable pharmacokinetic profile 67 Capecitabine 67 hyperphenylalaninemia HPA due 67 ibandronate 67 nab paclitaxel 67 rFIXFc 67 Lubiprostone 67 lucinactant 67 Gemzar ® 67 HBeAg positive patients 67 elagolix 67 Targretin 67 adecatumumab MT# 67 biliary tract cancer 67 adalimumab Humira 67 rALLy clinical trial 67 Thiovir 67 Altastaph 67 OncoVEX 67 Phase 1b clinical trials 67 cidofovir 67 small molecule Hedgehog 67 class mGluR5 inhibitor 67 TO AVOID PREGNANCY WHILE 67 torezolid phosphate 67 Herceptin trastuzumab 67 BENICAR HCT 67 advanced carcinoid 67 Melphalan 67 Asentar 67 L BLP# 67 Hsp# Inhibitor 67 Voreloxin 67 Genz # 67 Fulvestrant 67 Squalamine 67 GAMMAGARD 67 rNAPc2 67 CINQUIL 67 R lenalidomide 67 taxane resistant 67 Exelixis XL# 67 veltuzumab 67 BRIM2 67 GRN# 67 Eculizumab 67 methylnaltrexone bromide 67 triphendiol 67 TOCOSOL Paclitaxel 67 uric acid lowering 67 Enzastaurin 67 ALN PCS 67 Phase Ib II 67 pegylated interferon alpha 2a 67 mRCC 67 oral methylnaltrexone 67 Meets Primary Endpoint 67 radezolid 67 CYC# 67 vorinostat 67 IAP inhibitors 67 pharmacokinetic PK study 67 lintuzumab 67 Bortezomib 67 Trofex 67 subcutaneous SC 67 multi kinase inhibitor 67 BCIRG 67 Inhaled nitric oxide 67 SomatoKine 67 octreotide 67 metastatic colorectal 67 lenalidomide dexamethasone 67 Cloretazine R VNP#M 67 MGCD# [001] 67 RAPAFLO 67 EFAPROXYN 67 arsenic trioxide injection 67 abacavir lamivudine 67 CAELYX 67 Aurora kinase 67 Albuferon TM 67 #mg dose [002] 67 oral FTY# 67 sargramostim 67 plus prednisone prednisolone 67 selective adenosine 67 oral picoplatin 67 GOUT 67 Romidepsin 67 OMNARIS HFA 67 Phase Ib clinical trials 67 relapsed refractory multiple myeloma 67 imatinib Gleevec ® 67 pegylated interferon alpha 67 SUPPRELIN R LA 67 ponatinib 67 Crofelemer budesonide foam 67 TNF Tumor Necrosis Factor 67 CA9 SCAN 67 #ME# 67 COPEGUS 67 refractory CLL 67 Solazed TM 67 ISIS # 67 Vitaxin 67 Cetrorelix 67 taxane chemotherapy 67 ocrelizumab 67 vapreotide acetate 67 rFVIIIFc 67 Proxinium TM 67 OvaRex MAb 67 TREANDA 67 Radezolid 67 accumulate preferentially 67 SERMs 67 EVIZON TM 67 MYDICAR ® 67 JAK1 67 VALSTAR 67 dexamethasone Decadron 67 Blinatumomab 67 acetonide FA 67 Lixivaptan 67 phase IIb study 67 Dacogen decitabine 67 protease inhibitor PI 67 CORT # 67 Gliadel Wafer 67 HDL Selective Delipidation 67 Panzem 67 Tavocept 67 TORISEL 67 Janus kinase 67 TRISENOX 67 dose cohorts 67 Liposomal 67 incyclinide 67 Triolex 67 Phase III Pivotal 67 Pegylated Liposomal Doxorubicin 67 Adjuvant chemotherapy 67 mGluR5 NAM 67 liposomal amphotericin B 67 oral antiviral 67 Interferon alfa 67 CCR9 antagonist 67 Nuvion 67 RSD# oral 67 anthracycline taxane 67 delafloxacin 67 Androxal TM 67 Decitabine 67 PEG Interferon lambda 67 APOPTONE 67 sufentanil 67 refractory acute myeloid 67 Pivotal Phase III 67 DCVax R 67 gastrointestinal stromal tumor GIST 67 OMP #R# 67 temsirolimus 67 tiuxetan 67 vandetanib 67 TH# [003] 67 Bosutinib 67 MTP inhibitor 67 5-fluorouracil/leucovorin 67 QLT# 67 AVONEX ® 67 vinca alkaloid 66 YERVOY 66 oral clodronate 66 ARIKACE ™ 66 DexaSite 66 Antiangiogenic 66 REGN# 66 neratinib 66 luteinizing hormone releasing 66 iniparib 66 pediatric acute lymphoblastic 66 humanised monoclonal antibody 66 nucleotide analog 66 HCV protease 66 regorafenib 66 IV Busulfex 66 maximally tolerated dose 66 AZT zidovudine Retrovir 66 EGFR TKI 66 myeloproliferative diseases 66 dose escalation phase 66 trial evaluating PRX# 66 FOLOTYN ® 66 chemotherapy FOLFOX 66 topical gel containing 66 PLK1 SNALP 66 imatinib Gleevec 66 rALLy 66 relapsed leukemia 66 sJIA 66 BEXXAR Therapeutic Regimen 66 HCV RESPOND 2 66 lexidronam injection 66 Cotara 66 Triapine R 66 FOLFOX6 66 KSP inhibitor 66 ApoB SNALP 66 KRAS mutations occur 66 esophageal candidiasis 66 Dacogen injection 66 trastuzumab Herceptin ® 66 TAXOTERE R 66 Ocrelizumab 66 IMiDs ® 66 PROCHYMAL 66 dextromethorphan quinidine 66 OncoGel 66 NeuroSTAT ® 66 Curaxin CBLC# 66 INT# [002] 66 AMEVIVE 66 XmAb# 66 LHRH receptor positive 66 human IgG1 monoclonal 66 Taxotere chemotherapy 66 HSP# inhibitor 66 vinorelbine tartrate 66 PD LID 66 dacetuzumab 66 MNTX 66 cediranib 66 Nexavar ® 66 RLY# 66 Metastatic Melanoma 66 Anturol TM 66 coadministration 66 VELCADE melphalan 66 Initiate Phase 66 glufosfamide 66 Hsp# inhibition 66 INCB# [003] 66 ruxolitinib 66 ORENCIA ® 66 androgen independent 66 APTIVUS r 66 dirucotide 66 IMC A# 66 GMX# 66 acute GvHD 66 IMiDs ® compound 66 DFMO 66 omacetaxine mepesuccinate 66 Vicriviroc 66 assessing T DM1 66 inhaled liposomal ciprofloxacin 66 Zorbtive TM 66 phase Ib 66 placebo controlled Phase 66 Phase #b/#a trial 66 immunotherapeutic agent 66 Firazyr 66 somatostatin analog 66 Pivotal Phase 66 BCG refractory carcinoma 66 Topotecan 66 motesanib 66 plus DOXIL 66 gemtuzumab ozogamicin 66 BEXXAR 66 telaprevir dosed 66 induce remission 66 #mg/m# [002] 66 Phase Ib clinical 66 azacitidine 66 MVA BN 66 Hsp# inhibitors 66 platelet inhibitor 66 mg kg dose 66 Eltrombopag 66 Canvaxin TM 66 LymphoStat B 66 relapsing remitting MS RRMS 66 gemcitabine Gemzar 66 alpha 2a 66 selective androgen receptor modulator 66 administered intranasally 66 gemcitabine Gemzar ® 66 olaparib 66 delivers fluocinolone acetonide FA 66 refractory NSCLC 66 CHOP chemotherapy 66 Hodgkin lymphoma HL 66 Tectin TM 66 THR beta agonist 66 Hycamtin ® 66 chronic idiopathic thrombocytopenic purpura 66 evaluating mipomersen 66 dosing cohorts 66 INTEGRILIN ® 66 anthracyclines taxanes 66 low dose cytarabine 66 polymerase inhibitor 66 mGluR2 NAM 66 Dalbavancin 66 alefacept 66 unresectable stage 66 Phase 1a clinical 66 R roscovitine 66 AZILECT R 66 pediatric malignancies 66 Panzem NCD 66 bevacizumab Avastin 66 AEZS 66 vemurafenib 66 MEK inhibitors 66 Zoraxel 66 Fidaxomicin 66 refractory AML 66 relapsed multiple myeloma 66 ospemifene 66 metastatic pancreatic 66 tafamidis 66 mitomycin 66 eribulin mesylate 66 essential thrombocythemia ET 66 mitoxantrone plus 66 ARRY # 66 stage IIIB 66 Sorafenib Nexavar 66 metastatic GIST 66 GFT# 66 Neupogen ® 66 eosinophilic asthma 66 ONCASPAR 66 Anthracycline 66 Lucanix R 66 somatostatin analogue 66 aleglitazar 66 Neoadjuvant 66 EDEMA3 66 evaluating T DM1 66 resistant hormone refractory 66 investigational immunotherapy 66 pegylated interferon alfa 2a 66 Phase 1b trial 66 midstage trials 66 HCV protease inhibitor 66 RNAi therapeutic targeting 66 BioNumerik 66 Fludarabine 66 rapid virologic response 66 verteporfin 66 UVIDEM 66 INVANZ 66 BRAF V# mutation 66 Bendamustine 66 hour bronchodilation 66 Granulocyte Colony Stimulating Factor 66 FOLFOX4 66 #I TM# 66 tamoxifen citrate 66 Liprotamase 66 5 HT3 antagonist 66 dose limiting toxicities 66 STRIDE PD 66 LCP Tacro 66 NEUVENGE 66 PRADAXA 66 JAK2 inhibitor 66 cis retinoic acid 66 PEG interferon 66 novel oral anticoagulant 66 sunitinib Sutent ® 66 Onalta 66 tositumomab 66 MabCampath 66 Platinol ® cisplatin 66 oncolytic virus therapies 66 limiting toxicity 66 rFSH 66 Lovaxin C 66 rituximab Rituxan 66 ALK inhibitor 66 PEG PAL 66 humanized interleukin 6 66 hormone LHRH antagonist 66 EXPAREL TM 66 Diabetic Macular Edema 66 Navelbine ® 66 Phase IIa trials 66 locoregional recurrence 66 pharmacodynamic effects 66 poly ADP ribose polymerase 66 APTIVUS 66 TAFA# 66 GTC recombinant human 66 Proleukin 66 chlorambucil 66 Genasense ® oblimersen 66 HCV replicon 66 Patients Treated With 66 tubulin inhibitor 66 lead Aganocide compound 66 Argatroban 66 5 HT2A inverse 66 Fx #A 66 taxane refractory 66 Viramidine 66 elvucitabine 66 Telcyta 66 Telik logo TELINTRA 66 ChronVac C R 66 Enzyme Replacement Therapy 66 fallopian tube carcinoma 66 Sanctura XR 66 Genentech Rituxan 66 ALN VSP 66 Combination REOLYSIN R 66 NS#/#A protease 66 TEMODAL 66 mTOR inhibitor 66 Alferon N 66 RSD# 66 refractory multiple myeloma 66 bicalutamide 66 mTOR inhibitors 66 cangrelor 66 stage IIIb IV 66 phase III isavuconazole 66 IV bolus 66 calcineurin inhibitors 66 Etoposide 66 squalamine 66 Mg Usa 66 postoperative chemotherapy 66 Telbivudine 66 Pruvel 66 subcutaneous PRO 66 dexpramipexole 66 ATACAND 66 Tocosol Paclitaxel 66 efalizumab 66 differentiated thyroid 66 sunitinib Sutent 66 immune modulating 66 Initiate Clinical Trial 66 Dabigatran etexilate 66 carboplatin paclitaxel 66 highly selective inhibitor 66 Hepatocellular Carcinoma HCC 66 thetreatment 66 achieved CCyR 66 bortezomib Velcade R 66 systemic immunosuppressive drugs 66 vosaroxin 66 polycythemia vera essential thrombocythemia 66 LHRH antagonists 66 PDE# inhibitors 66 liposomal doxorubicin 66 Maximum Tolerated Dose MTD 66 radiolabeled TM# 66 topical gel formulation 66 MVA BN R 66 PROVENGE sipuleucel T 66 mg TID 66 Octreolin 66 letrozole Femara 66 VIDAZA 66 IRESSA 66 desvenlafaxine succinate 66 Inhalation Solution 66 Denufosol 66 subcutaneous formulation 66 FROVA 66 PEGINTRON TM 66 alemtuzumab treated 66 Relivar 66 neurologic progression 66 Jevtana